Recipharm has secured a five-year $114.9 million loan for future expansion plans in the field of contract pharmaceutical development. The company plans to increase capital investment in existing sites and facilities, as well as support a program of strategic acquisitions. Resources will also be assigned to building and enhancing existing and new customer relationships.
 
Thomas Eldered, chief executive officer of Recipham AB, said, “The new financing will serve to bolster initiatives designed to build and foster strong customer relationships with all our clients across the pharmaceuticals sector. Recipharm adopts a partnering approach to client relations to ensure that we consistently provide bespoke services that meet the precise needs of each individual customer both now and in the future. Our program of strategic acquisitions and investment in current facilities has always been geared towards increasing and expanding the services that we tailor to each specific client. We look forward to continuing in this vein.”